Myospect Molecular Imaging

MyoSPECT Molecular Imaging Recall Summary MyoSPECT Molecular Imaging is being recalled across Canada due to performance issues. This is a Class I recall, which indicates a serious concern. The product is used for molecular imaging procedures and affects patients in Canada who may have received or been scheduled for this imaging service.

Product
MyoSPECT Molecular Imaging
Reason
Performance
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DEVICES
Recall date
2024-05-07
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/33a6d727-50f5-4c94-abb6-3299873f7b78